首页> 外文会议>Annual meeting exposition of the Controlled Release Society >Liposomal Formulations of Prilocaine with Prolonged Anesthetic Action: Effect of Drug Complexation with HPβCD
【24h】

Liposomal Formulations of Prilocaine with Prolonged Anesthetic Action: Effect of Drug Complexation with HPβCD

机译:具有延长麻醉作用的普林兰脂质体配方:药物络合与HPβCD的影响

获取原文

摘要

Liposomal formulations of prilocaine rilocaine were developed to improve the drug therapeutic efficacy. Different possibilities of drug entrapment in the vesicles (as hydrochloride salt or as equimolar complex with HPβCD in the aqueous phase, or as free base in the lipid phase) have been investigated. The obtained liposomal suspensions were characterized for zeta potential, particle size, entrapment efficiency and evaluated in vivo for drug anesthetic effect. The mo most effective formulation was st obtained by double double-loading of free base in the membrane bilayer and the complex in the aqueous core. The combined use of cyclodextrin and liposomal carriers allowed the highest reduction of the onset time and prolongation of the duration of the anesthetic effect.
机译:开发了普里兰氏毒素的脂质体配方,以改善药物治疗疗效。已经研究了不同的药物夹带的不同可能性(作为水相中的HPβCD或盐期的等摩尔络合物,或作为脂质相中的游离碱)。所获得的脂质体悬浮液的特征在于Zeta电位,粒度,熵效率,并在体内评估毒药麻醉效应。通过在膜双层和含水核中的复合物中双加载游离碱而获得的ST获得Mo最有效的制剂。环糊精和脂质体载体的组合使用允许最快减少的发作时间和麻醉效应持续时间的延长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号